Modulation of Angiogenesis for Cancer Prevention: Strategies Based On Antioxidants and Copper Deficiency

Author(s): Gazala N. Khan, Sofia D. Merajver

Journal Name: Current Pharmaceutical Design

Volume 13 , Issue 35 , 2007

Become EABM
Become Reviewer
Call for Editor


Although anti- angiogenesis strategies have generated much enthusiasm for therapeutic applications, it is still unknown whether they would be feasible for prevention. The possibility of interfering very early in tumor progression by modulating the cancer angiogenic switch is appealing. In this chapter, we review progress with in vitro and in vivo models that show that anti-angiogenic interventions may be amenable to long- term chemopreventive measures. In particular, some approaches that are nearly ready for major applications are anti-oxidant nutraceuticals and copper deficiency. We use these strategies as paradigms of how to make progress in this difficult but important area of translational research.

Keywords: Angiogenesis, cancer prevention, anti-oxidants, nutraceuticals, copper chelation, in vivo studies, tetrathiomolybdate

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2007
Page: [3584 - 3590]
Pages: 7
DOI: 10.2174/138161207782794202
Price: $65

Article Metrics

PDF: 5